Noorik Biopharmaceuticals Ag

This study is testing whether a drug called ambrisentan can help people with hepatorenal syndrome, a serious kidney complication that occurs in advanced liver cirrhosis and often leads to death. Researchers are comparing ambrisentan against the standard treatment, terlipressin, i…